Chemotherapy News and Research

Latest Chemotherapy News and Research

A metabolic intermediate in the uronic acid pathway impairs lung cancer metastasis

In a study published online in Nature on June 26, research teams led by Dr. YANG Weiwei at the Institute of Biochemistry and Cell Biology of the Chinese Academy of Sciences and Dr. LI Guohui from the Dalian Institute of Chemical Physics of CAS reported a new function of uridine diphosphate glucose (UDP-glucose), a metabolic intermediate in the uronic acid pathway: It impairs lung cancer metastasis by accelerating SNAI1 mRNA decay.

27 Jun 2019

Heat from nanoparticles zaps cancer cells from inside

Oregon State University researchers have come up with nanoclusters that are capable of reaching within tumours that are difficult to reach. The results of this breakthrough in cancer therapeutics were published in a study in the latest issue of the journal ACS Nano.

26 Jun 2019

New findings may help kick-start aging immune system

The thymus is the powerhouse producing the immune system's T cells, which combat infection in our body.

26 Jun 2019

3D mammograms increasing in popularity for breast cancer screening in the USA

More and more women are undergoing 3D mammograms for breast cancer screening in the US, with rates increasing from 13 percent to 43 percent.

26 Jun 2019

Novel combination therapy shown to be safe and effective for prostate cancer patients

A novel therapy using two targeted treatments for prostate cancer has been shown to maximize efficacy while reducing side effects according to research presented at the Society of Nuclear Medicine and Molecular Imaging 2019 Annual Meeting.

26 Jun 2019

LSU Health researchers to investigate link between breast cancer and obesity in real time

Frank Lau, MD, Associate Professor in the Section of Plastic and Reconstructive Surgery at LSU Health New Orleans School of Medicine, has been awarded a grant by the Southeastern Society of Plastic Surgeons to improve the care and research of breast cancer and obesity.

25 Jun 2019

Researchers explore new immune checkpoint for head and neck cancer

A checkpoint may delay travelers but it can help give cancer free rein by suppressing the natural immune response that should destroy it, researchers say.

25 Jun 2019

Engineered cell evolution may provide a path to reduce chemotherapy resistance

A significant problem when treating cancer patients remains drug resistance, which often causes chemotherapy treatments to ultimately fail.

25 Jun 2019

New chemoimmunotherapy regimen for aggressive form of lymphoma gets FDA approval

A cancer therapy based on the work of Ben Seon, PhD, at Roswell Park Comprehensive Cancer Center has been approved by the U.S. Food and Drug Administration for patients with an aggressive form of non-Hodgkin lymphoma.

24 Jun 2019

Study calls for more aggressive treatments to improve 5-year survival in glioblastoma patients

Despite improvements in median and short-term survival rates for patients with glioblastoma, the most common brain tumor in adults, the percentage of patients achieving five-year survival remains low, according to new Mayo Clinic research.

23 Jun 2019

Timed release of curcumin inhibits cancer cell growth

A Washington State University research team has developed a drug delivery system using curcumin, the main ingredient in the spice turmeric, that successfully inhibits bone cancer cells while promoting growth of healthy bone cells.

21 Jun 2019

Chemotherapy can wreak havoc on the heart

Cheryl Krafft was diagnosed with an aggressive form of non-Hodgkin's lymphoma and was put on a very high-powered chemotherapy regimen to rid her body of the cancer. What she was not counting on was the chemotherapy causing another equally deadly problem.

21 Jun 2019

Sortilin protein plays crucial role in pain development

Sortilin, which is a protein expressed on the surface of nerve cells, plays a crucial role in pain development in laboratory mice - and in all likelihood in humans as well.

21 Jun 2019

Study emphasizes need for more aggressive treatments for glioblastoma patients

20 Jun 2019

New chief medical officer appointed for Cancer Research UK’s Centre for Drug Development

Professor Peter Johnson will be the new chief medical officer for Cancer Research UK’s Centre for Drug Development, it was announced today (Tuesday).

19 Jun 2019

Postmenopausal breast cancer survivors at greater risk for developing heart disease

Thanks to advanced medical treatments, women diagnosed with breast cancer today will likely survive the disease.

19 Jun 2019

Novel approach of blocking inflammation before surgical procedure may prevent cancer recurrences

A growing body of evidence suggests that traditional cancer treatments can paradoxically promote new tumor growth.

19 Jun 2019

Study shows how methods limited to physics can be of great use in cancer research

A new study on the behavior of water in cancer cells shows how methods usually limited to physics can be of great use in cancer research.

19 Jun 2019

Study links high number of copies of chromosomal region to chemotherapeutic drug resistance

Researchers at the Bellvitge Biomedical Research Institute, with the participation of collaborators from the Baylor College of Medicine and the University Institute of Oncology of Asturias, publish today in Cancer Research a study where they relate the high number of copies of a chromosomal region with the appearance of resistance to a chemotherapeutic drug.

19 Jun 2019

Henry Ford Cancer Institute treats its first patient with CAR T-cell therapy

Henry Ford Cancer Institute has treated its first patient with CAR T-cell therapy, an approach that uses engineered cells from a patient's immune system to destroy cancer.

18 Jun 2019

Chemotherapy News and Research

Latest Chemotherapy News and Research

A metabolic intermediate in the uronic acid pathway impairs lung cancer metastasis

Heat from nanoparticles zaps cancer cells from inside

New findings may help kick-start aging immune system

3D mammograms increasing in popularity for breast cancer screening in the USA

Novel combination therapy shown to be safe and effective for prostate cancer patients

LSU Health researchers to investigate link between breast cancer and obesity in real time

Researchers explore new immune checkpoint for head and neck cancer

Engineered cell evolution may provide a path to reduce chemotherapy resistance

New chemoimmunotherapy regimen for aggressive form of lymphoma gets FDA approval

Study calls for more aggressive treatments to improve 5-year survival in glioblastoma patients

Timed release of curcumin inhibits cancer cell growth

Chemotherapy can wreak havoc on the heart

Sortilin protein plays crucial role in pain development

Study emphasizes need for more aggressive treatments for glioblastoma patients

New chief medical officer appointed for Cancer Research UK’s Centre for Drug Development

Postmenopausal breast cancer survivors at greater risk for developing heart disease

Novel approach of blocking inflammation before surgical procedure may prevent cancer recurrences

Study shows how methods limited to physics can be of great use in cancer research

Study links high number of copies of chromosomal region to chemotherapeutic drug resistance

Henry Ford Cancer Institute treats its first patient with CAR T-cell therapy

Cancer Research - Second Edition eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Chemotherapy News and Research

Latest Chemotherapy News and Research

Cancer Research - Second Edition eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in